SoCal's Peregrine Names a New CEO, to Change Name to Avid Bioservices
Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests. Source: BioSpace
Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests. Source: BioSpace
Shire filed its first submission to the FDA for its new plasma manufacturing site in Covington, Georgia. Source: BioSpace
Novartis announced today that the FDA approved the inclusion of Treatment-free Remission data in the Tasigna U.S. product label. Source: BioSpace
2018 is the year for Rakesh Kapoor to show he's worth it. Source: BioSpace
A look at a biotech company that represents a solid trend in the industry. Source: BioSpace
It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases. Source: BioSpace
Janssen Biotech announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA and Legend to develop, manufacture and commercialize a CAR T-cell drug…
Celgene announced the Phase III results late Thursday and share prices dropped about 4 percent to $102.69 as of 9:30 this morning. Source: BioSpace
North Carolina sued Insys on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic. Source:…
Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace